메뉴 건너뛰기




Volumn 68, Issue 21, 2011, Pages 2062-2068

Vancomycin dosage in overweight and obese children

Author keywords

Antibiotics; Blood levels; Dosage; Dosage schedules; Injections; Obesity; Toxicity; Vancomycin

Indexed keywords

VANCOMYCIN;

EID: 80455144700     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110107     Document Type: Article
Times cited : (28)

References (18)
  • 1
    • 38449122349 scopus 로고    scopus 로고
    • Assessment of child and adolescent overweight and obesity
    • Krebs NF, Himes JH, Jacobson D et al. Assessment of child and adolescent overweight and obesity. Pediatrics. 2007; 120 (suppl 4):S193-228.
    • (2007) Pediatrics , vol.120 , Issue.SUPPL. 4
    • Krebs, N.F.1    Himes, J.H.2    Jacobson, D.3
  • 2
    • 74549159752 scopus 로고    scopus 로고
    • Prevalence of high body mass index in US children and adolescents, 2007-2008
    • Ogden CL, Carroll MD, Curtin LR et al. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010; 303:242-9.
    • (2010) JAMA , vol.303 , pp. 242-249
    • Ogden, C.L.1    Carroll, M.D.2    Curtin, L.R.3
  • 3
    • 74549182660 scopus 로고    scopus 로고
    • Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children
    • Miller JL, Johnson PN, Harrison DL et al. Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children. Ann Pharmacother. 2010; 44:35-42.
    • (2010) Ann Pharmacother , vol.44 , pp. 35-42
    • Miller, J.L.1    Johnson, P.N.2    Harrison, D.L.3
  • 4
    • 0024309467 scopus 로고
    • Prediction of the distribution volumes of cefazolin and tobramycin in obese children based on physiological pharmacokinetic concepts
    • Koshida R, Nakashima E, Taniguchi N et al. Prediction of the distribution volumes of cefazolin and tobramycin in obese children based on physiological pharmacokinetic concepts. Pharm Res. 1989; 6:486-91. (Pubitemid 19182185)
    • (1989) Pharmaceutical Research , vol.6 , Issue.6 , pp. 486-491
    • Koshida, R.1    Nakashima, E.2    Taniguchi, N.3    Tsuji, A.4    Benet, L.Z.5    Ichimura, F.6
  • 5
    • 33845909601 scopus 로고    scopus 로고
    • Pharmacokinetic alterations in obesity
    • Lee JB, Winstead PS, Cook AM. Pharmacokinetic alterations in obesity. Orthopedics. 2006; 29:984-9.
    • (2006) Orthopedics , vol.29 , pp. 984-989
    • Lee, J.B.1    Winstead, P.S.2    Cook, A.M.3
  • 6
    • 80455156944 scopus 로고    scopus 로고
    • Vancomycin monograph
    • Taketomo CK, Hodding JH, Kraus DM, eds. 17th ed. Hudson, OH: Lexi-Comp Inc.
    • Vancomycin monograph. In: Taketomo CK, Hodding JH, Kraus DM, eds. Pediatric dosage handbook, 17th ed. Hudson, OH: Lexi-Comp Inc.; 2010.
    • (2010) Pediatric Dosage Handbook
  • 7
    • 80455156941 scopus 로고    scopus 로고
    • Vancomycin monograph
    • Lacy CF, Armstrong LL, Goldman MP et al., eds. 19th ed. Hudson, OH: Lexi-Comp Inc.
    • Vancomycin monograph. In: Lacy CF, Armstrong LL, Goldman MP et al., eds. Drug information handbook, 19th ed. Hudson, OH: Lexi-Comp Inc.; 2010.
    • (2010) Drug Information Handbook
  • 8
    • 0034106774 scopus 로고    scopus 로고
    • Dosage adjustments for antibacterials in obese patients
    • Bearden DT, Rodvold KA. Dosage adjustments for antibacterials in obese patients. Clin Pharmacokinet. 2000; 38:415-26.
    • (2000) Clin Pharmacokinet , vol.38 , pp. 415-426
    • Bearden, D.T.1    Rodvold, K.A.2
  • 9
  • 10
    • 0033800745 scopus 로고    scopus 로고
    • Effects of obesity on pharmacokinetics: Implications for drug therapy
    • Cheymol G. Effects of obesity on pharmacokinetics: implications for drug therapy. Clin Pharmacokinet. 2000; 39:215-31.
    • (2000) Clin Pharmacokinet , vol.39 , pp. 215-231
    • Cheymol, G.1
  • 11
    • 33646696219 scopus 로고    scopus 로고
    • CLSI-approved standard M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute
    • Performance standards for antimicrobial susceptibility testing. CLSI-approved standard M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
    • (2006) Performance Standards for Antimicrobial Susceptibility Testing
  • 12
    • 62449183879 scopus 로고    scopus 로고
    • Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health- System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
    • Rybak M, Lomaestro B, Rotschafer JC et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health- System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm. 2009; 66:82-98.
    • (2009) Am J Health-Syst Pharm , vol.66 , pp. 82-98
    • Rybak, M.1    Lomaestro, B.2    Rotschafer, J.C.3
  • 13
    • 67649543995 scopus 로고    scopus 로고
    • Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate
    • Frymoyer A, Hersh AL, Benet LZ et al. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J. 2009; 28:398-402.
    • (2009) Pediatr Infect Dis J , vol.28 , pp. 398-402
    • Frymoyer, A.1    Hersh, A.L.2    Benet, L.Z.3
  • 14
    • 77950208675 scopus 로고    scopus 로고
    • Should higher vancomycin trough levels be targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children?
    • Jimenez-Truque N, Thomsen I, Saye E et al. Should higher vancomycin trough levels be targeted for invasive community-acquired methicillin-resistant Staphylococcus aureus infections in children? Pediatr Infect Dis J. 2010; 29:368-70.
    • (2010) Pediatr Infect Dis J , vol.29 , pp. 368-370
    • Jimenez-Truque, N.1    Thomsen, I.2    Saye, E.3
  • 15
    • 1042276996 scopus 로고    scopus 로고
    • Clinical Features Associated with Bacteremia Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
    • DOI 10.1086/381093
    • Charles PG, Ward PB, Johnson PD et al. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin Infect Dis. 2004; 38:448-51. (Pubitemid 38200128)
    • (2004) Clinical Infectious Diseases , vol.38 , Issue.3 , pp. 448-451
    • Charles, P.G.P.1    Ward, P.B.2    Johnson, P.D.R.3    Howden, B.P.4    Grayson, M.L.5
  • 16
    • 67651113645 scopus 로고    scopus 로고
    • Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients
    • Lodise TP, Patel N, Lomaestro BM et al. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009; 49:507-14.
    • (2009) Clin Infect Dis , vol.49 , pp. 507-514
    • Lodise, T.P.1    Patel, N.2    Lomaestro, B.M.3
  • 18
    • 0017195506 scopus 로고
    • A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine
    • Schwartz GJ, Haycock GB, Edelmann CM Jr et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics. 1976; 58:259-63.
    • (1976) Pediatrics , vol.58 , pp. 259-263
    • Schwartz, G.J.1    Haycock, G.B.2    Edelmann Jr., C.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.